Virological breakthrough after therapy with ombitasvir + paritaprevir / ritonavir + dasabuwir in a patient with the 1b genotype of viral hepatitis C
Abstract
A clinical case of a virologic breakthrough in a patient with a 1b genotype after a 12-week therapy with ombitasvir + paritrapeprivir / ritonavir + dasabuvir, due to significant mutations in the NS3, NS5a, and NS5b region of the virus is presented.
About the Authors
N. B. Voloshina
Federal State Budget Educational Institution of Higher Education «Novosibirsk State Medical University» of the Ministry of Health of Russia (FSBEI HE NSMU MOH Russia)
Russian Federation
Russian Federation
I. O. Voloshina
Center for New Medical Technologies
Russian Federation
Russian Federation
S. I. Cholin
Federal State Budget Educational Institution of Higher Education «Novosibirsk State Medical University» of the Ministry of Health of Russia (FSBEI HE NSMU MOH Russia)
Russian Federation
Russian Federation
Review
For citations:
Voloshina N.B., Voloshina I.O., Cholin S.I. Virological breakthrough after therapy with ombitasvir + paritaprevir / ritonavir + dasabuwir in a patient with the 1b genotype of viral hepatitis C. Experimental and Clinical Gastroenterology. 2018;(7):158-160. (In Russ.)
Views:
304
Email this article 